Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (254K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Zhang, S.
Right arrow Articles by Isaksson, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, S.
Right arrow Articles by Isaksson, L. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 Oxford University Press 4301-4306

The efficiency of a cis-cleaving ribozyme in an mRNA coding region is influenced by the translating ribosome in vivo

The efficiency of a cis -cleaving ribozyme in an mRNA coding region is influenced by the translating ribosome in vivo Shaoping Zhang+, Martin Stancek and Leif A. Isaksson*

Department of Microbiology, Stockholm University, S-106 91 Stockholm, Sweden

Received July 7, 1997; Revised and Accepted September 19, 1997

ABSTRACT

A cis-cleaving hammerhead ribozyme (Rz) expression system (3A'-Rz) in Escherichia coli has been constructed that can be used to study the involvement of factors that affect ribozyme cleavage in vivo. The ribozyme sequence is placed in the coding region of 3A' mRNA, which is expressed from a semi-synthetic translation assay gene. The size and the 5'-end sequences of the 3' cleavage fragments were determined and the efficiencies of different Rz variants were measured by quantitative primer extension. It is shown that one of the semi-active constructs (3A'-RzIII) can be used as an indicator for ribosomes that read through or terminate at a stop codon upstream of the Rz hammerhead sequence in the mRNA. Readthrough of the stop codon in an uncleaved mRNA gives a full length 3A' protein. Termination at the stop codon upstream of the ribozyme sequence gives a shortened termination product. However, the mRNA fragment that should arise as a result of the autocleavage does not give rise to any detectable corresponding truncated protein. Besides studies on translating ribosomes, the 3A'-Rz system can be used to isolate mutant strains that are changed in ribozyme activity either from internal base alterations, or changed interacting host factors.

INTRODUCTION

Ribozymes (Rz) are small RNA molecules that are capable of catalyzing an RNA cleavage reaction in a sequence-specific manner (1 ). Hammerhead-type ribozymes, which were originally discovered through studies of plant viroid and satellite RNA (2 -4 ), are particularly attractive. They can promote an in cis (intramolecular) self-cleavage at the 3' side of a GUC triplet; however, they can also be engineered to work in trans (intermolecular) (5 ,6 ). Hammerhead ribozymes can be designed to cleave any RNA substrate containing an NUX triplet, where N can be any nucleotide and X can be C, A or U (but not G). The cleavage results in two RNA fragments: one with a 2',3'-cyclic phosphate end and another with a 5'-OH end (6 ).

The catalytic determinants for the ribozyme-catalyzed cleavage reaction are not well understood. Ribozymes that are very active in vitro can have a much lower activity in vivo (7 ,8 ). They are considered to be potential therapeutic agents and have been used to study gene expression, mostly in eukaryotic cells (9 -13 ). Only a few cases have been reported for ribozyme activity in a natural bacterial system (14 -16 ).

Our objective with this study is to construct a cis-cleaving hammerhead ribozyme that can self-cleave the 3A' translation assay gene mRNA in Escherichia coli in vivo (17 -19 ). This gene is semi-synthetic and codes for three identical domains of an engineered B-domain of the antibody-binding protein A from Staphylococcus aureus. The protein gene product can be collected using affinity chromatography on a Sepharose-immunoglobulin G column in one step. A linker between the second and third coding domains can be used to insert hammerhead ribozyme sequences which thus catalyse autocleavage of the mRNA. The system has the advantage that both full length and truncated gene products can be studied. It can also be used to study the influence of intracellular factors that affect ribozyme efficiency. In this report we use this system to study the influence of ribosomes that translate along the 3A' mRNA, thus disturbing the activity of the cis-cleaving ribozyme. Ribozyme activity is dependent on formation of its correct, three-dimensional folded structure (20 -22 ). A translating ribosome should therefore interfere with formation of the hammerhead structure necessary for cleavage. Thus, translation and self-cleavage would be competing reactions. The level of self-cleavage would therefore reflect the level of pausing by approaching ribosomes at codons upstream of the hammerhead structure.

MATERIALS AND METHODS

Plasmid constructions

Plasmid pAB25 was provided by A.Björnsson (this laboratory) and contains a 3A' reporter gene. It was constructed by cloning the 3A' gene from pAB4 (without the secretion signal) (17 ) into pAB22 (18 ). All plasmid constructs used in this study are derived from pAB25 (Fig. 1 A). By using standard recombinant DNA techniques (23 ), various Rz sequences (Fig. 1 B) with a CAG or UAG codon upstream of the hammerhead sequence were inserted into the EcoRI-BamHI cloning site of the 3A' gene, between the second and the third A' coding domains (Fig. 1 A). The E.coli strain MG1655 was used to transform all recombinant plasmids. The 3A'-Rz constructs used are listed in Table 1 .


Figure 1. (A) The 3A'-Rz expression system derived from pAB25. Transcription is controlled by the Ptrc promoter and induced by adding IPTG. Transcription is terminated at Ttrp. The insertion region for various cis-cleaving Rz sequences is indicated and is specified in (B). The upstream codon, which is denoted as NNN, is either CAG or UAG. (B) Inserted ribozyme sequences using the EcoRI and BamHI sites giving the indicated secondary ribozyme structures. The cleavage site (GUX) as indicated by a dotted arrow is either GUC (active) or GUG (inactive). The various changes of mutant Rz are indicated. Solid line arrows indicate base substitutions (RzII, RzIV) or replacement of the small stem-loop 1 with a larger sequence giving RzIII (lacking stop codons and with a maintained translational reading frame).

In vitro transcription

Plasmid pAB9, which can be used for in vitro transcription assay of the 3A' gene, was provided by A.Björnsson. The 3A' gene of pAB9 was replaced by different 3A'-Rz sequences located downstream of the T3 promoter. The plasmids were linearized by cleaving at the PstI site, which is located at the 3' end of the 3A'-Rz gene. The in vitro transcription reaction was performed according to the standard protocol from Promega. T3 RNA polymerase was from Promega.

Northern blot analysis of 3A'-mRNA

Total RNA was isolated from MG1655, which carries various plasmid constructs, using a hot-phenol method (24 ,25 ). Escherichia coli cultures (30 ml) were grown in M9 medium as previously described (26 ). Growth was stopped in mid-log phase and the cultures were cooled rapidly on ice. An aliquot of 20 ml of each culture was used for total RNA preparation and the remaining 10 ml was saved for protein A assay, as described below. Northern blot and oligo-probe labelling was performed as described by Sambrook et al. (23 ). A 32P-labelled probe ABSO1 (5'-CGTTGTTCTTCGTTTAAGTTAGG-3'), which can hybridize to each A' coding domain of 3A' mRNA, was used for hybridization. A standard RNA marker mixture was purchased from GIBCO BRL.

Primer extension analysis

Primer extension of 3A'-Rz mRNA was performed using an AMV Reverse Transcriptase Primer Extension system from Promega. A 32P-labelled primer ABPO2 (5'-CTTACTTAAGCTTGGCTGCAG-3'), which is complementary to the 3' end of the 3A'-Rz mRNA, was used. DNA sequencing of pSP115 was performed, with the same primer (ABPO2) as a size marker. Gels were dried and scanned using PhosphoImager to quantify the primer extension products.

Analysis of protein products from 3A'-Rz mRNA

Protein A products expressed from the various 3A'-Rz constructs in MG1655 were isolated and analyzed as described previously (27 ).

RESULTS

The 3A' translational assay system was used to create a system which expresses a cis-cleaving ribozyme that can auto-cleave a translatable mRNA in E.coli, (see Materials and Methods). This system contains three repeats of a reporter gene (3A') coding for a modified IgG-binding B domain of protein A from S.aureus (Fig. 1 A). Transcription, controlled by the Ptrc promoter, is inducible by IPTG (isopropyl [beta]-d-thiogalactopyranoside). Various Rz sequences (Fig. 1 B) were inserted into a linker region between the second and third coding domain, giving the constructs outlined in Table 1 . RzI is regarded here as a wild-type (wt) ribozyme, as described by Haseloff and Gerlach (6 ), and originates from the (+) strand of sTobRV RNA; RzII is the same as RzI but has GUG at the cleavage site; RzIII is a mutation of RzI and has a larger loop 1. RzIV is a mutation of RzI with the change of A13 to C13; RzV is another derivative of RzI with a deletion of bases C3 through A9.

Table 1 . Plasmid constructs
Plasmid NNN Ribozyme GUX (cleavage site)
pSP115 CAG RzI (Wt) GUC
pSP44 CAG RzII GUG
pSP71 CAG RzIII GUC
pSP43 CAG RzIV GUC
pSP87a CAG RzV GUC
pSP39 UAG RzI (Wt) GUC
pSP40 UAG RzII GUG
pSP64 UAG RzIII GUC
pSP87b UAG RzV GUC
Constructs were made as described in Materials and Methods. The various Rz sequences are shown in Figure 1. NNN denotes the codon 36 nucleotides upstream of the Rz sequence. The cleavage site GUX is either GUC or GUG.

The cleavage activities of Rz were examined by Northern blot analysis of 3A' mRNA (Fig. 2 A). The cleaved and uncleaved products can be detected by hybridization using the radioactive labelled probe ABSO1, which is complementary to a sequence in each A' coding mRNA region. Wild-type RzI with GUC (RzI) at the cleavage site (Fig. 1 and Table 1 ) cleaves 3A' mRNA into one 5' and one 3' fragment with very high efficiency, as evidenced by two strong bands of cleavage products (Fig. 2 A) corresponding to 2A' mRNA and 1A' mRNA. The Northern blot analysis does not give reliable quantitative measurements. Even so, the relative amounts found for 3A' mRNA and the 2A' and 1A' fragments suggest that RzI is efficiently autocleaved whereas RzIII is less efficient. This suggests that the non-conserved loop 1 can influence the proper ribozyme conformation in vivo. Plasmid pSP44, which contains RzII with GUG at the cleavage site, has very little or no ribozyme activity. No cleavage product can be detected for the mutant RzV (pSP87a), suggesting that the deletion of nucleotides C3-A9 abolishes ribozyme activity. Another construct, pSP43, which contains a point mutation at position 13 (RzIV), has also lost its activity. This observation is in line with the finding that the nucleotide A13, located within the conserved central domain of the hammerhead, is required for proper formation of the tertiary structure (21 ). Mutation of most of the single strand nucleotides in the central core results in a reduction of the cleavage rate (20 ).


Figure 2. Northern blot analysis of 3A'-Rz mRNA in E.coli. The Rz used in each lane is indicated. The probe (ABSO1) is hybridized to the full-length 3A'-Rz mRNA (752 bp for RzI), the 5' cleavage fragment (468 bp for RzI) and the 3' cleavage fragment (284 bp for RzI). The sizes of the RNA markers are indicated. UI: unidentified band. (A) Total RNA was isolated from MG1655, which expresses Rz constructs with the upstream codon CAG. (B) Total RNA was isolated from MG1655 which expresses Rz constructs with the upstream codon UAG. The first lanes in (A) and (B) contain an RNA sample from strain MG1655 with plasmids pSP87a and pSP87b without addition of the IPTG inducer.

Northern blot analysis of 3A' mRNA with the stop codon UAG upstream of the ribozyme sequence (Fig. 1 ) was performed, the results of which are seen in Figure 2 B. Wild-type RzI with UAG upstream (pSP39) shows similar high cleavage activity as RzI with CAG upstream (pSP115). Cleavage efficiency of the latter ribozyme is apparently too high to even be disturbed by ribosomes that are translating the CAG sense codon. Also, introduction of the UAG stop codon upstream of the inactive RzII and RzV (pSP40 and pSP87b) does not enhance their activities. In contrast, cleavage efficiencies increase when UAG is present upstream of RzIII (pSP64). This result is further confirmed by a quantitative primer extension experiment, showing that the RzIII efficiency increases from 20 to 56% when the upstream codon CAG is changed to UAG (Fig. 3 ).


Figure 3. Cleavage efficiency of ribozyme derivatives with UAG or CAG upstream of the ribozyme sequence. Primer extension reaction samples were run together with the sequencing marker on a 6% polyacrylamide-7 M urea gel. The gel was dried and subjected to quantitative analysis of the 32P-labelled probe using a PhosphorImager. Cleavage efficiency for the indicated ribozyme derivatives was calculated by measuring the molar amounts of 3A' and 1A' mRNA.

For in vitro studies, various 3A'-Rz constructs were subcloned into an in vitro assay system, pAB9, under the control of the T3 promoter (25 ). The results of the in vitro transcription reaction fail to discriminate between the wild-type RzI and mutant RzIII in terms of cleavage activity. The kinetics of cleavage were similar at early time points and both 3A' mRNAs were completely cleaved in 30 min. Other ribozymes, RzII and RzV, show no or very little activity, in accordance with the in vivo results (not shown).


Figure 4. Primer extension analysis of 3A'-Rz mRNAs. The name of each plasmid is indicated. The primer ABPO2 is annealed to the sequence at the 3' end of 3A'-Rz mRNA. The full-length mRNA and the 3' cleavage fragments are indicated. RzI (pSP115 and pSP39) and RzIII (pSP71 and pSP64) produce two extension products while the other constructs produce only a full-length product. The first lane contains an DNA sample obtained without using the IPTG inducer. DNA sequencing of pSP115 was performed using the same primer (ABPO2) and run on the same gel in order to determine the sizes and the 5' end sequences of the cleavage fragments. The deduced mRNA sequence showing the cleavage site is shown.

In order to quantify ribozyme activities quantitative primer extension was used instead of Northern blot analysis. The size and the 5' end sequences of the distal cleavage products of the 3A'-Rz mRNAs were also determined. Comparison with a sequence marker showed that wild-type RzI and mutant RzIII cleave 3A' mRNA precisely at the cleavage site on the 3' side of the GUC triplet (Fig. 4 , pSP115, pSP39, pSP71, pSP64). The size of the distal fragments generated by RzI and RzIII are 284 and 302 nucleotides, respectively. The cleavage efficiency can be estimated by a quantitative radioactivity assay in which a PhosphoImager is used to compare the 3' fragment (A') to the full-length fragment (3A'). The results (Fig. 3 ) are consistent with the Northern blot assay results described above: the wild-type RzI (pSP115) is 90% efficient while mutant RzIII (pSP71) shows 20% efficiency. The results suggest that the ribozyme RzIII is less efficient in vivo than RzI even though they appear to be similar in vitro. This indicates that other cellular factors interfere with the in vivo cleavage reaction. The replacement of CAG with UAG about 30 bases upstream of the ribozyme sequence increases cleavage efficiency of RzIII from ~20 to 60%.

We next analyzed the translation products of the 3A'-Rz expression gene (Fig. 5 ). It can be seen that constructs with a UAG upstream of the Rz sequence give rise to a 2A' protein product, resulting from termination at the stop codon. As expected, since the UAG stop codon is efficient, no full length 3A' protein can be seen. Constructs with CAG instead of UAG give a full length 3A' protein as the sole product. It is consistently observed that cells with this construct have a lower cellular level of the 3A' protein than observed for other constructs. No truncated protein product, which would correspond to the 5' autocleavage fragment of RzI (pSP115) and RzIII (pSP71), can be seen for any of the constructs. Such truncated protein, being a C-terminal extended 2A', would be expected for these plasmids.


Figure 5. Protein products from different 3A'-Rz mRNAs. 3A' and 2A' proteins in strains with the indicated plasmids were isolated by affinity chromatography and analyzed by SDS-gel-electrophoresis (18 and references therein). The identities of the protein products are indicated.

DISCUSSION

Ribosomes translate codons along the mRNA at a rate of 5-20 amino acids/s (28 ,29 ). Some codons can thus be classified as `fast' whereas others are `slow'. Often, but not always, a `slow' codon is rare and is decoded by a minor tRNA species (30 ). `Fast' codons are enriched in highly expressed genes (31 ,32 ). Termination codons are also decoded at different variable speeds and UAG is decoded faster by RF1 than UGA is by RF2 (19 ,26 ). Both these codons can be read by a near-cognate or a suppressor tRNA, thus giving increased translational readthrough of the stop codon. Such readthrough is dependent on the efficiency of the tRNA and termination factor as well as the codon context (26 ,27 ,33 -35 ).

Decoding a stop codon takes longer than decoding a sense codon (28 ,36 ). If a ribosome pauses at a stop codon far enough upstream of the Rz sequence, priority is given to the folding of the ribozyme into its three-dimensional structure and a higher cleavage activity should be obtained. We tested this hypothesis by introducing a UAG stop codon into the 3A'-Rz expression system, in place of a CAG codon located 36 nucleotides upstream of the Rz sequence. A ribosome that pauses at this position should cover about 20 bases downstream in the mRNA (37 ) and it should therefore not interfere with formation of ribozyme secondary structure. The results suggest that RzIII is disturbed differently by translating ribosomes, depending on whether CAG or UAG is the codon upstream of Rz. Since there is no translation after the mRNA has been extracted for analysis, the observed codon influence on ribozyme activity should take place in the cell, and not in connection with the isolation procedure. The results support the idea that a cis-cleaving ribozyme can be used as an indicator for translating ribosomes that enter the ribozyme-specific structure. Slowly translated codons should lower the speed at which the ribosome moves along the mRNA, thereby giving the cleavage reaction more time to occur. Conversely, quickly translating ribosomes can disturb the hammerhead conformation by breaking up the secondary structure, thus reducing the cleavage efficiency. For stop codons, only ribosomes that read through the stop codon will disturb the ribozyme auto-cleavage.

The possibility that UAG instead of CAG upstream of the ribozyme sequence in itself has some effect on mRNA degradation by some unknown cellular system should be considered. Ribozyme cleavage efficiency is calculated on the basis of molar amounts of the 1A' and 3A' cleavage products. After cleavage the UAG/CAG codons are located in the 2A' fragment which is not used for the calculation. Thus, stability of 1A' should not be affected. The remaining possibility would be that the pools of 3A' mRNA with UAG or CAG are different. In order to explain the observed effect on RzIII efficiency being ~60 and 20%, respectively, these mRNA pools should vary several-fold. Such large variation would have been detected in our experiments. Thus, we have no reason to suspect that the UAG/CAG codons upstream of the ribozyme sequence by themselves have any effect on mRNA degradation by some unknown cellular system.

The protein assays confirm that the UAG termination codon placed upstream of the Rz sequence is efficient, because this results in only the 2A' termination product and no full-length 3A' protein. The expression of the 2A' protein from these constructs suggests that the leading part of the mRNA, coding for 2A', is not rapidly degraded as a secondary result of the ribozyme activity in the cases of RzI and RzIII. Constructs with CAG instead of UAG (pSP115) give only the full length 3A' protein product and its cellular level seems to be reduced. However, it is a significant finding that no truncated protein corresponding to the RzI auto-cleaved truncated mRNA can be found. This is a noteworthy result since in our experience similar proteins, which are the result of termination at an appropriate stop codon instead of ribosome run off from a truncated mRNA, are formed and are stable (not shown). The lack of a truncated protein in pSP115 carrying cells could mean that its coding mRNA fragment or the protein itself is degraded. This would be in line with the finding of a reduced amount of 3A' protein in the pSP115 cells. One possibility is that CAG in the ribozyme generated mRNA fragment specifically induces fragment degradation by some secondary pathway, which is not triggered by UAG at the same codon location. Even if we regard this model as unlikely it could explain why we can find a protein which results from termination at a stop codon whereas we fail to find a truncated protein that results from ribosome run off. However, in view of the remarkable specificity by 10Sa RNA, coded by the ssrA gene, we instead favor a model that the truncated proteins that are coded by the autocleavage-generated truncated mRNA fragment are indeed formed but are rapidly broken down via the ssrA and the tsp protease system (38 ,39 ). In this case, the 10Sa RNA would bind to the empty A-site that is exposed as the translating ribosome comes to the 3' end of the cleaved mRNA, that lacks a stop codon. Through trans-translation the ribosome would then extend the truncated A' gene product by using the 3' part of the 10Sa RNA that has mRNA activity. The fused protein would finally be broken down by the Tsp protease (38 ). Further investigation is needed in the involvement of the ssrA, tsp system in the degradation of the truncated protein that arises from the ribozyme-generated mRNA fragment.

In a recent report a mutant E.coli strain with slow ribosomes has been used to minimize the interference from translating ribosomes with ribozyme duplex formation and cleavage, thus making selection of mutants in ribozyme interfering factors possible (40 ). The various 3A'-Rz constructs described here catalyze self-cleavage of 3A' mRNA with different efficiencies. It should be possible to fuse an appropriate selective reporter gene giving, for instance, antibiotic resistance to the end of the 3A' gene. Selection for increased antibiotic resistance should then give ribozyme variants with increased efficiency. Similarly, if the reporter gene gives disadvantages for cellular growth, increased ribozyme activity should counteract formation of the distal fusion partner, thus giving improved cellular growth. Thus, by choosing appropriate reporter genes it should be possible to select ribozyme sequences that are increased or decreased in efficiency, or to identify potential host factors that improve or inhibit in vivo ribozyme activity. Furthermore, our constructs can be used to examine how the translation machinery interferes with the auto-cleavage reaction.

ACKNOWLEDGEMENTS

We thank Monica Rydén-Aulin for her contribution in the initial part of this project, Asgeir Björnsson for advice and gifts of the plasmids pAB9 and pAB25 and Steve Muir for comments on the manuscript. This work was supported by grants from the Swedish Council for Technical Research (TFR) and the Harald Jeansson, Harald and Greta Jeansson Foundations.

REFERENCES

1 Rossi,J.J. (1992) Curr. Opin. Biotechnol., 3, 3-7. MEDLINE Abstract

2 Buzayan,J.M., Gerlach,W.L. and Bruening,G. (1986) Proc. Natl. Acad. Sci. USA, 83, 8859-8862.

3 Prody,G.A., Bakos,J.T., Buzayan,J.M., Schneider,I.R. and Bruening,G. (1986) Science, 231, 1577-1580.

4 Symons,R.H. (1989) Trends Biochem. Sci., 14, 445-450. MEDLINE Abstract

5 Uhlenbeck,O.C. (1987) Nature, 328, 596-600. MEDLINE Abstract

6 Haseloff,J. and Gerlach,W.L. (1988) Nature, 334, 585-591. MEDLINE Abstract

7 L'Huillier,P.J., Davis,S.R. and Bellamy,A.R. (1992) EMBO J., 11, 4411-4418.

8 Lo,K.M.S., Biasolo,M.A., Dehni,G., Pal,G. and Haseltine,W.A. (1992) Virology, 190, 176-183.

9 Sarver,N., Cantin,E.M, Chang,P.S., Zaia,J.A., Ladne,R.A., Stephens,D.A. and Rossi,J.J. (1990) Science, 247, 1222-1224. MEDLINE Abstract

10 Scanlon,K.J., Jiao,L., Funato,T., Wang,W., Tone,T., Rossi,J.J. and Kashani-Sabet,M. (1991) Proc. Natl. Acad. Sci. USA, 88, 10591-10595. MEDLINE Abstract

11 Sioud,M., Natriz,J.B. and Forre,O. (1992) J. Mol. Biol., 223, 831-835. MEDLINE Abstract

12 Steinecke,P., Herget,T. and Schreier,P.H. (1992) EMBO J., 11, 1525-1530. MEDLINE Abstract

13 Sczakiel,G. and Nedbal,W. (1995) Trends Microbiol., 3, 213-217. MEDLINE Abstract

14 Altman,S. (1993) Proc. Natl. Acad. Sci. USA, 90, 10898-10900. MEDLINE Abstract

15 Inokuchi,Y., Yuyama,N., Hirashima,A., Nishikawa,S., Ohkawa,J. and Taira,K. (1994) J. Biol. Chem., 269, 11361-11366. MEDLINE Abstract

16 Fujita,S., Koguma,T., Ohkawa,J., Mori,K., Kohda,T., Kise,H., Nishikawa,S., Iwakura,M. and Taira,K. (1997) Proc. Natl. Acad. Sci. USA, 94, 391-396. MEDLINE Abstract

17 Björnsson,A. and Isaksson,L.A. (1993) J. Mol. Biol., 232, 1017-1029.

18 Björnsson,A., Mottagui-Tabar,S. and Isaksson,L.A. (1997) Methods Mol. Biol. (Protein Synthesis: Methods and Protocols), 77, in press.

19 Björnsson,A., Mottagui-Tabar,S. and Isaksson,L.A. (1996) EMBO J., 15, 1696-1704.

20 Ruffner,D.E., Stormo,G.D. and Uhlenbeck,O.C. (1990) Biochemistry, 29, 10695-10702. MEDLINE Abstract

21 Ruffner,D.E. and Uhlenbeck,O.C. (1990) Nucleic Acids Res., 18, 6025-6029. MEDLINE Abstract

22 Perrotta,A.T. and Been,M.D. (1991) Nature, 350, 434-436. MEDLINE Abstract

23 Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) A Laboratory Manual (2nd edit.) Cold spring Harbor Laboratory Press, Cold Spring Harbor, NY.

24 von Gabain,A., Belasco,J.G., Schottel,J.L., Chang,A.C.Y. and Cohen,S.N. (1983) Proc. Natl. Acad. Sci. USA, 80, 653-657. MEDLINE Abstract

25 Björnsson,A. (1994) The influence of codon context on translation termination and messenger RNA levels. Ph.D. thesis, Stockholm University.

26 Zhang,S.P., Rydén-Aulin,M. and Isaksson,L.A. (1996) J. Mol. Biol., 261, 98-107.

27 Mottagui-Tabar,S., Björnsson,A. and Isaksson,L.A. (1994) EMBO J., 13, 249-257.

28 Andersson,D.I., Bohman,K., Isaksson,L.A. and Kurland,C.G. (1982) Mol. Gen. Genet., 187, 467-472. MEDLINE Abstract

29 Sørensen,M.A. and Pedersen,S. (1991) J. Mol. Biol., 222, 265-280.

30 Bonekamp,F. and Jensen,K.F. (1988) Nucleic Acids Res., 16, 3013-3024. MEDLINE Abstract

31 Holm,L. (1986) Nucleic Acids Res., 14, 3075-3087. MEDLINE Abstract

32 Sørensen,M.A., Kurland,C.G. and Pedersen,S. (1989) J. Mol. Biol., 207, 365-377.

33 Buckingham,R.H., Sörensen,P., Pagel,F.T., Hijazi,K.A, Mims,B.H., Brechemier-Baey,D. and Murgola,E.J. (1990) Biochim. Biophys. Acta, 1050, 259-262. MEDLINE Abstract

34 Pedersen,W.T. and Curran,J.F. (1991) J. Mol. Biol., 219, 231-241. MEDLINE Abstract

35 Yarus,M. and Curran,J. (1992) In Hatfield,D.L., Lee,B.Y. and Pirtle,R.M. (eds), Transfer RNA in Protein Synthesis. CRC Press, Boca Raton, pp. 319-365.

36 Björnsson,A. and Isaksson,L.A. (1996) Nucleic Acids Res., 24, 1753-1757.

37 Beyer,D., Skripkin,E., Wadzack,J. and Nierhaus,K.H. (1994) J. Biol. Chem., 269, 30713-30717. MEDLINE Abstract

38 Keiler,K.C., Waller,P.R. and Sauer,R.T. (1996) Science, 271, 990-993. MEDLINE Abstract

39 Komine,Y., Kitabatake,M., Yokogawa,T., Nishikawa,K. and Inokuchi,H. (1994) Proc. Natl. Acad. Sci. USA, 91, 9223-9227. MEDLINE Abstract

40 Chen,H., Ferbeyre,G. and Cedergren,R. (1997) Nature Biotech., 15, 432-435.


*To whom correspondence should be addressed. Tel: +46 8 164197; Fax: +46 8 6129552; Email: leif.isaksson@mibi.su.se
+Present address: School of Biological Sciences, University of Auckland, Auckland, New Zealand


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Print PDF (254K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Zhang, S.
Right arrow Articles by Isaksson, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, S.
Right arrow Articles by Isaksson, L. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?